ATORVASTATIN CALCIUM
- Product NDC
- 68071-2293
- 11-digit product format
- 680712293
- Labeler code
- 68071
- Product ID
- 68071-2293_d5922e83-0461-06ae-e053-2a95a90a368e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ATORVASTATIN CALCIUM
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA205945
- Marketing category
- ANDA
- Marketing start
- 2020-01-01
- Marketing end
- 0000-00-00
- Substance
- ATORVASTATIN CALCIUM TRIHYDRATE
- Active strength
- 40 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-2293-9 | 68071229309 | 90 TABLET, FILM COATED in 1 BOTTLE (68071-2293-9) | 2020-11-16 | 0000-00-00 | No | No | Current |